関節内補充療法市場：製品、供給源、用途、最終用途別-2025-2030年世界予測

関節内補充療法市場は、2023年に28億3,000万米ドルと評価され、2024年には30億1,000万米ドルに達すると予測され、CAGR 6.19％で成長し、2030年には43億2,000万米ドルに達すると予測されています。

関節内補充療法は、関節にヒアルロン酸を注入して痛みを緩和し、主に変形性関節症の患者の可動性を向上させる医療処置です。関節内補充療法の必要性は、従来の治療法では不十分な場合に大きな緩和をもたらす可能性があるためであり、外科的選択肢の前の中間的な解決策として機能します。その用途は主に整形外科的治療、特に変形性膝関節症であるが、股関節、足首、肩関節にもその用途が広がっています。最終用途は病院や診療所から外来手術センターまで幅広く、さまざまなヘルスケア環境での適応性を反映しています。市場成長の主な原動力は、世界人口の高齢化、変形性関節症の有病率の上昇、外科的治療以外の選択肢に対する意識の高まりです。ヒアルロン酸製剤の技術的進歩や、低侵襲手技への注目の高まりは、さらに需要を刺激します。アジア太平洋のような未開拓の新興市場にビジネスチャンスがあり、そこではヘルスケアインフラの改善が市場参入を促進しています。優れた効能をもたらす、より長持ちする製剤や送達方法の開発には、横断的な機会があります。しかし、関節内補充療法にかかるコストや一貫性のない償還政策などの制約があり、また、患者の反応性のばらつきや、副腎皮質ステロイドや多血小板血漿療法などの代替治療との競合などの課題もあります。技術革新と研究は、徐放性ヒアルロン酸製品や、治療効果を高めるために抗炎症剤を組み込んだ併用療法など、新しいデリバリープラットフォームに焦点を当てるべきです。市場は激しい競争と急速な進歩を特徴としているため、業界各社は絶えず革新を続け、変化する規制シナリオと顧客の期待に適応していかなければならないです。企業はデジタルチャネルを活用し、ヘルスケア専門家と患者に治療の利点を啓蒙して普及を促進すべきです。患者中心の調査を優先し、臨床適応症を拡大することが、今後の市場の成功には不可欠です。

市場力学：急速に進化する関節内補充療法市場の主要市場インサイトを公開

関節内補充療法市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 変形性関節症の非外科的治療に対するニーズの高まり
  • 食生活の変化に伴う生活習慣病の増加
  • 世界の老年人口と肥満の急増
• 市場抑制要因
  • ヒアルロン酸ベースの治療による副作用と高コスト
• 市場機会
  • ヒアルロン酸ベースの治療法開発における進行中の進歩
  • 膝蓋軟骨症における関節内補充療法の役割の拡大
• 市場の課題
  • 厳しい承認規制と潤滑・鎮痛効果の持続時間の短さ

ポーターのファイブフォース：関節内補充療法市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：関節内補充療法市場における外部からの影響の把握

外部マクロ環境要因は、関節内補充療法市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析関節内補充療法市場における競合情勢の把握

関節内補充療法市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス関節内補充療法市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、関節内補充療法市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 変形性関節症に対する非外科的治療の必要性の高まり
    • 食習慣の変化による生活習慣病の発生増加
    • 高齢者人口と肥満が世界的に急増
  • 抑制要因
    • ヒアルロン酸ベースの治療の副作用と高額な費用
  • 機会
    • ヒアルロン酸ベースの治療法の開発における継続的な進歩
    • 膝蓋軟骨症における関節内補充療法の役割の拡大
  • 課題
    • 承認のための厳格な規制義務と潤滑および鎮痛の持続期間の短さ
• 市場セグメンテーション分析
  • 製品：変形性関節症患者の痛みを軽減し、可動性を高めるための3回注射療法の採用が急増
  • 出典：過敏症反応のリスクを排除するため、非動物由来のヒアルロン酸が好まれる傾向が高まっている
  • アプリケーション：変形性膝関節症に対する関節内補充療法治療の進化するアプリケーション
  • 最終用途：整形外科クリニック/外来手術センター（ASC）における関節内補充療法治療の利用の拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境
• 顧客のカスタマイズ

第6章 関節内補充療法市場：製品別

• 5回の注射
• 単回注射
• 3回の注射

第7章 関節内補充療法市場：ソース別

• 動物
• 非動物

第8章 関節内補充療法市場：用途別

• 手の変形性関節症
• 変形性股関節症
• 変形性膝関節症

第9章 関節内補充療法市場：最終用途別

• 病院
• 整形外科クリニック/外来手術センター（ASC）

第10章 南北アメリカの関節内補充療法市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の関節内補充療法市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの関節内補充療法市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • KiOmed PharmaとArsylabは、難治性膝関節症の新しい治療であるKioMedinevsoneのフランスにおける販売促進と流通に関する戦略的提携を発表
  • アニカのシンガルが第3相試験で主要評価項目を達成

企業一覧

• Avanos Medical, Inc.
• Viatris Inc.
• LG Chem Ltd.
• Anika Therapeutics, Inc.
• Quimfa S.A.
• Sanofi S.A.
• Contipro A.S.
• Lifecore Biomedical, LLC
• Smith & Nephew PLC
• Bioventus LLC
• Fidia Farmaceutici S.p.A.
• Alcon Inc.
• Seikagaku Corporation
• Teva Pharmaceutical Industries Ltd.
• F. Hoffmann-La Roche Ltd.
• Ferring B.V.
• Zimmer Biomet
• Regen Lab SA
• Gentex Pharma, LLC
• Bausch Health Companies Inc.
• AbbVie Inc.
• DePuy Synthes by Johnson & Johnson Services, Inc.

LIST OF FIGURES

• FIGURE 1. VISCOSUPPLEMENTATION MARKET RESEARCH PROCESS
• FIGURE 2. VISCOSUPPLEMENTATION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. VISCOSUPPLEMENTATION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. VISCOSUPPLEMENTATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. VISCOSUPPLEMENTATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. VISCOSUPPLEMENTATION MARKET DYNAMICS
• TABLE 7. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ANIMAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY NON-ANIMAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HAND OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HIP OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ORTHOPEDIC CLINICS/AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 34. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 36. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 56. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 58. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 60. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 62. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 88. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 92. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 96. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 105. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 109. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 113. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 117. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 121. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 125. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 129. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 131. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 133. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 137. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 141. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 145. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 147. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 149. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 150. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 151. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 153. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 157. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 165. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 169. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 173. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 177. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 185. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 189. VISCOSUPPLEMENTATION MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 190. VISCOSUPPLEMENTATION MARKET, FPNV POSITIONING MATRIX, 2023

The Viscosupplementation Market was valued at USD 2.83 billion in 2023, expected to reach USD 3.01 billion in 2024, and is projected to grow at a CAGR of 6.19%, to USD 4.32 billion by 2030.

Viscosupplementation is a medical procedure involving the injection of hyaluronic acid into joints to alleviate pain and improve mobility, primarily for those with osteoarthritis. The necessity of viscosupplementation arises due to its potential to provide significant relief where conventional therapies may not suffice, acting as an intermediate solution before surgical options. Its application is mainly in orthopedic care, particularly for knee osteoarthritis, although research is expanding its use to hip, ankle, and shoulder joints as well. End-use spans from hospitals and clinics to ambulatory surgical centers, reflecting its adaptability in various healthcare settings. Market growth is chiefly driven by the aging global population, the rising prevalence of osteoarthritis, and increasing awareness of non-surgical treatment alternatives. Technological advancements in hyaluronic acid formulations and the growing focus on minimally invasive procedures further stimulate demand. Opportunities lie in untapped emerging markets like Asia-Pacific, where improving healthcare infrastructure is fostering market entry. There is a cross-sectional opportunity in developing enhanced, longer-lasting formulations and delivery methods that could provide superior efficacy. However, limitations include the cost of viscosupplementation and inconsistent reimbursement policies, while challenges include variability in patient response and competition from alternative treatments like corticosteroids and platelet-rich plasma therapies. Innovation and research should focus on novel delivery platforms, such as sustained-release hyaluronic acid products or combination therapies that incorporate anti-inflammatory agents to enhance treatment outcomes. The market is characterized by strong competition and rapid advancements, thus industry players must continuously innovate and adapt to shifting regulatory scenarios and customer expectations. Companies should leverage digital channels to educate healthcare professionals and patients on treatment benefits to drive adoption. Prioritizing patient-centric research and expanding clinical indications will be crucial for future market success.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Viscosupplementation Market

The Viscosupplementation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing Need for Non-Surgical Treatment for Osteoarthritis
  • Rising Occurrence of Lifestyle-Induced Disorders with Changing Eating Habits
  • Surge in Geriatric Population and Obesity Globally
• Market Restraints
  • Side Effects and High Cost of The Hyaluronic Acid-Based Treatment
• Market Opportunities
  • Ongoing Advancements in the Development of Hyaluronic Acid-Based Therapies
  • Extending Role of Viscosupplementation in Patellar Chondropathy
• Market Challenges
  • Strict Regulatory Mandates for Approval and Short Duration of Lubrication and Pain Relief

Porter's Five Forces: A Strategic Tool for Navigating the Viscosupplementation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Viscosupplementation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Viscosupplementation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Viscosupplementation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Viscosupplementation Market

A detailed market share analysis in the Viscosupplementation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Viscosupplementation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Viscosupplementation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Viscosupplementation Market, highlighting leading vendors and their innovative profiles. These include Avanos Medical, Inc., Viatris Inc., LG Chem Ltd., Anika Therapeutics, Inc., Quimfa S.A., Sanofi S.A., Contipro A.S., Lifecore Biomedical, LLC, Smith & Nephew PLC, Bioventus LLC, Fidia Farmaceutici S.p.A., Alcon Inc., Seikagaku Corporation, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche Ltd., Ferring B.V., Zimmer Biomet, Regen Lab SA, Gentex Pharma, LLC, Bausch Health Companies Inc., AbbVie Inc., and DePuy Synthes by Johnson & Johnson Services, Inc..

Market Segmentation & Coverage

This research report categorizes the Viscosupplementation Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Five Injection, Single Injection, and Three Injection.
• Based on Source, market is studied across Animal and Non-animal.
• Based on Application, market is studied across Hand Osteoarthritis, Hip Osteoarthritis, and Knee Osteoarthritis.
• Based on End-use, market is studied across Hospitals and Orthopedic Clinics/Ambulatory Surgical Centers (ASCs).
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing Need for Non-Surgical Treatment for Osteoarthritis
    • 5.1.1.2. Rising Occurrence of Lifestyle-Induced Disorders with Changing Eating Habits
    • 5.1.1.3. Surge in Geriatric Population and Obesity Globally
  • 5.1.2. Restraints
    • 5.1.2.1. Side Effects and High Cost of The Hyaluronic Acid-Based Treatment
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing Advancements in the Development of Hyaluronic Acid-Based Therapies
    • 5.1.3.2. Extending Role of Viscosupplementation in Patellar Chondropathy
  • 5.1.4. Challenges
    • 5.1.4.1. Strict Regulatory Mandates for Approval and Short Duration of Lubrication and Pain Relief
• 5.2. Market Segmentation Analysis
  • 5.2.1. Products: Burgeoning adoption of a three-injection regimen to reduce pain and enhance mobility in patients with osteoarthritis
  • 5.2.2. Source: Growing preference for non-animal-based hyaluronic acid as it eliminates hypersensitivity reaction risks
  • 5.2.3. Applications: Evolving applications of viscosupplementation treatment for knee osteoarthritis
  • 5.2.4. End-use: Proliferating utilization of viscosupplementation treatment in orthopedic clinics/ambulatory surgical centers (ASCs)
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization

6. Viscosupplementation Market, by Product

• 6.1. Introduction
• 6.2. Five Injection
• 6.3. Single Injection
• 6.4. Three Injection

7. Viscosupplementation Market, by Source

• 7.1. Introduction
• 7.2. Animal
• 7.3. Non-animal

8. Viscosupplementation Market, by Application

• 8.1. Introduction
• 8.2. Hand Osteoarthritis
• 8.3. Hip Osteoarthritis
• 8.4. Knee Osteoarthritis

9. Viscosupplementation Market, by End-use

• 9.1. Introduction
• 9.2. Hospitals
• 9.3. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)

10. Americas Viscosupplementation Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Viscosupplementation Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Viscosupplementation Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. KiOmed Pharma and Arsylab Announce Strategic Partnership for the Promotion and Distribution in France of KioMedinevsone, a New Class of Treatment for Refractory Knee Osteoarthritis
  • 13.3.2. Anika's Cingal Successfully Achieves Primary Endpoint in Third Phase III Study

Companies Mentioned

• 1. Avanos Medical, Inc.
• 2. Viatris Inc.
• 3. LG Chem Ltd.
• 4. Anika Therapeutics, Inc.
• 5. Quimfa S.A.
• 6. Sanofi S.A.
• 7. Contipro A.S.
• 8. Lifecore Biomedical, LLC
• 9. Smith & Nephew PLC
• 10. Bioventus LLC
• 11. Fidia Farmaceutici S.p.A.
• 12. Alcon Inc.
• 13. Seikagaku Corporation
• 14. Teva Pharmaceutical Industries Ltd.
• 15. F. Hoffmann-La Roche Ltd.
• 16. Ferring B.V.
• 17. Zimmer Biomet
• 18. Regen Lab SA
• 19. Gentex Pharma, LLC
• 20. Bausch Health Companies Inc.
• 21. AbbVie Inc.
• 22. DePuy Synthes by Johnson & Johnson Services, Inc.